No Data
No Data
Express News | GAUSH MEDITECH: The artificial lens implant system has obtained certification.
Announcement Highlights | Contemporary Amperex Technology will start its IPO on May 12, with the issue price not exceeding 263 Hong Kong dollars; Shandong Molong Petroleum Machinery: the controlling shareholder has cumulatively reduced their shareholding
① Guangzhou Automobile Group's April auto sales fell by over 10%, what is the impact? ② CHINA OVERSEAS's sales exceeded 66 billion yuan this year, what is the growth rate?
Gaush Meditech Units Gets Registration Nod for Lens Implant System From Guangdong Regulator
With the "outbound" strategy layered on top of a performance reversal, how will GAUSH MEDITECH (02407) save its significantly slowed liquidity?
Looking at the extended timeline, GAUSH MEDITECH's stock price fell by 3.53% throughout April, while the Hong Kong Medical Care Sector saw a rise of 1.10% during the same period. The underperformance compared to the sector may be related to GAUSH MEDITECH being removed from the Hong Kong Stock Connect and poor performance in the 2024 annual report.
GAUSH MEDITECH: ANNUAL REPORT 2024
Executive Director Zhao Xinli has increased Shareholding in GAUSH MEDITECH (02407) by 5,100 shares at a price of 5.2 Hong Kong dollars per share.
On April 9, Executive Director Zhao Xinli increased his shareholding in GAUSH MEDITECH (02407) by 5,100 shares, at a price of 5.2 Hong Kong dollars per share, totaling 0.02652 million Hong Kong dollars.